Blog

PatientPing’s National Community of ACO Providers Generate More than $270 Million in Shared Savings

Care coordination technology company aids its ACO provider network in achieving significant shared savings for 2017

BOSTONOct. 10, 2018 /PRNewswire/ — PatientPing, a health technology company that connects providers to seamlessly coordinate patient care, would like to congratulate its national network of Accountable Care Organizations (ACOs) for generating more than $270 million in shared savings in 2017 in the Medicare Shared Savings Program (MSSP). The care coordination technology company’s ACO network includes thousands of providers that participate in the MSSP and other innovative value-based-care delivery models.

“Patients transitioning across care settings are most at risk for readmissions, medication errors, and changes in providers, which can all lead to undesirable health outcomes and high costs,” said Denise Patriaco, Administrative Director at Hackensack Alliance ACO. “At Hackensack Alliance, we want to be sure that we keep a hand on the patient as they move from the hospital or ER to subacute care and then back home, with or without home health services. PatientPing has allowed us to keep track of a much larger segment of our population than we were able to before and has greatly assisted our ACO in decreasing overall readmissions.”

Read more

Buoy Health Named to CNBC’s 2018 Upstart 100 List Highlighting Innovation and Rapid Growth

BOSTON–(BUSINESS WIRE)–Oct 9, 2018–Buoy Health, an AI health assistant that helps people from the moment they get sick start their care on the right foot, today announced they have been named to CNBC’s inaugural 2018 Upstart 100 list. The CNBC Upstart 100 list highlights technology-driven start-ups that are experiencing rapid growth due to their innovative products, apps, tools or services. From hundreds of companies nominated from across the country, CNBC selected Buoy Health and its innovative artificial intelligence (AI) health assistant platform as one of the 100 up-and-coming companies with the potential to revolutionize, transform, and disrupt its industry.

Patients using Buoy Health simply visit www.buoyhealth.com and engage in a conversation with its friendly AI health assistant in an exchange designed to mirror a conversation with a doctor. Patients are then prompted through a series of questions to enter their symptoms in detail. Buoy will then analyze the patient’s inputs in real-time and direct the customer to a recommended course of treatment.

Read more

FAREVA Selects TraceLink to Comply with EU FMD Regulations

NORTH READING, Mass.Oct. 8, 2018 /PRNewswire/ — TraceLink Inc., the World’s Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, today announced that FAREVA has selected TraceLink’s serialization solutions to ensure compliance with the EU Falsified Medicines Directive (FMD). TraceLink and FAREVA will be at CPhI Worldwide, October 9 – 11 in Madrid, partnering together to provide education around EU FMD readiness and serialization.

A global pharmaceutical and API leading contract development and manufacturing organization (CDMO), FAREVA produces various dosage forms and API as well as offers packing options. With over 1,000 customers, FAREVA operates 35 sites across EuropeRussiaTurkey and The Americas.

Read more

Orchard Therapeutics plans $172.5 million U.S. IPO

Orchard Therapeutics is seeking to raise up to $172.5 million from a planned stock offering in the U.S., according to a regulatory filing.

The U.K. biopharmaceutical company, which has yet to post a profit, filed documents for the offering under Orchard RX Ltd. but said it would change its name to Orchard Therapeutics PLC. It plans to apply for its American depositary shares to trade on the Nasdaq under the symbol ORTX.

Read more

Carbonite CEO Mohamad Ali, CarGurus and Flywire Take Top Honors at 21st Annual Mass Technology Leadership Awards

BOSTON, Oct. 04, 2018 (GLOBE NEWSWIRE) — Massachusetts’ largest technology trade association announced the winners of the region’s most prestigious technology awards at their 21st annual Mass Technology Leadership Awards Gala at Boston’s Seaport World Trade Center. Hundreds gathered to celebrate the people and companies shaping the Massachusetts technology economy in 15 categories—including Massachusetts Company of the Year, CarGurus; Emerging Massachusetts Company of the Year, Flywire; and CEO of the Year, Carbonite’s Mohamad Ali.

In addition to the 15 industry-nominated awards, MassTLC highlighted the stories of three special leaders who’ve made significant contributions to the technology community. Technology pioneer, entrepreneur, investor and mentor, John Landry, received the Commonwealth Award, the Council’s highest honor, for a lifetime of contributions to tech. First-generation immigrant and former Global Chief Diversity officer for EMC, Jackie Glenn was honored with the Mosaic Award for inclusion. And, Technical Fellow and Director of Microsoft Research New England, New York and Montreal, Jennifer Chayes received the Council’s Distinguished Leadership Award for her contributions to the field of machine learning.

“The Mass Technology Leadership Awards celebrate the extraordinary leaders and innovators whose work is at the heart of our innovation economy,” said Tom Hopcroft, CEO, MassTLC. “Each year, I am honored to recognize the hardworking visionaries that are leading this state and the world, towards a better future.”

Read more

Carbonite CEO Mohamad Ali, CarGurus and Flywire Take Top Honors at 21st Annual Mass Technology Leadership Awards

BOSTON, Oct. 04, 2018 (GLOBE NEWSWIRE) — Massachusetts’ largest technology trade association announced the winners of the region’s most prestigious technology awards at their 21st annual Mass Technology Leadership Awards Gala at Boston’s Seaport World Trade Center. Hundreds gathered to celebrate the people and companies shaping the Massachusetts technology economy in 15 categories—including Massachusetts Company of the Year, CarGurus; Emerging Massachusetts Company of the Year, Flywire; and CEO of the Year, Carbonite’s Mohamad Ali.

In addition to the 15 industry-nominated awards, MassTLC highlighted the stories of three special leaders who’ve made significant contributions to the technology community. Technology pioneer, entrepreneur, investor and mentor, John Landry, received the Commonwealth Award, the Council’s highest honor, for a lifetime of contributions to tech. First-generation immigrant and former Global Chief Diversity officer for EMC, Jackie Glenn was honored with the Mosaic Award for inclusion. And, Technical Fellow and Director of Microsoft Research New England, New York and Montreal, Jennifer Chayes received the Council’s Distinguished Leadership Award for her contributions to the field of machine learning.

“The Mass Technology Leadership Awards celebrate the extraordinary leaders and innovators whose work is at the heart of our innovation economy,” said Tom Hopcroft, CEO, MassTLC. “Each year, I am honored to recognize the hardworking visionaries that are leading this state and the world, towards a better future.”

Read more

Buoy Health Receives Robert Wood Johnson Foundation Artificial Intelligence Award for Patient Health Education

BOSTON–(BUSINESS WIRE)–Buoy Health, an AI health assistant that helps people from the moment they get sick start their care on the right foot, today announced they were awarded the Robert Wood Johnson Foundation’s Artificial Intelligence (AI) Challenge Award for Patient Health Education at last month’s Health 2.0 Conference, held in Santa Clara, California. The award was the result of a year-long contest that asked companies to submit health-focused technologies incorporating AI. After being assessed against 250 competitors and advancing through multiple evaluation rounds, Buoy Health was chosen as one of three finalists. During a final live pitching session at the conference, the competition’s judges determined Buoy Health’s AI-powered chatbot technology to have the most impact, potential for adoption, creativity, scalability and design intuitiveness.

“We are honored to have received the AI Challenge Award from such a prestigious institution as the Robert Wood Johnson Foundation. Their recognition of Buoy Health’s AI health assistant as both a benefits tool for employers and a more helpful alternative for consumers that are prone to Googling their symptoms has emboldened us as we continue towards our goal of improving the patient journey,” said Dr. Andrew Le, CEO of Buoy Health. “Buoy was designed using real world data points based on trusted medical literature and guides patients to care by asking questions, just like a real doctor would. After a consumer answers questions for 2 to 3 minutes, we narrow the possible diagnoses and, through our employer, payer, and provider partners, show exactly what services exist for that particular ailment.”

Read more

TraceLink Surpasses 1,000 Customer Milestone, Including Over 500 Pharmaceutical Manufacturing Companies

NORTH READING, Mass., Oct. 3, 2018 /PRNewswire/ — TraceLink Inc., the World’s Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, today announced that it now serves over 1,000 customers in 43 countries, delivering proven solutions for companies that are complying with U.S. Drug Supply Chain Security Act (DSCSA), EU Falsified Medicines Directive (FMD) and additional track and trace requirements in RussiaIndiaSouth KoreaChina and Brazil.

In the third quarter of 2018, TraceLink reached 1,016 customers, representing a 46 percent year-over-year increase in total customers, including:

  • 63 percent representing pharmaceutical and contract manufacturers;
  • 5 percent representing wholesale distributors and parallel importers; and
  • 32 percent representing pharmacies, hospitals, clinics and health systems

Read more

Centogene, Denali Therapeutics Partner to Recruit Parkinson’s Patients for Drug Program

NEW YORK (GenomeWeb) – German diagnostics firm Centogene said today that it has entered into an agreement with Denali Therapeutics to conduct a targeted global patient identification and recruitment campaign for the company’s Parkinson’s disease LRRK2 inhibitor program.

Centogene will use its CentoCard, a proprietary dried blood spot collection kit, to collect samples that can identify Parkinson’s patients who carry mutations in the LRRK2 gene. According to the company, these mutations are one of the most commonly known genetic causes of Parkinson’s disease, driving lysosomal dysfunction, which contributes to the formation of Lewy body protein aggregates and neurodegeneration.

The arrangement is not Centogene’s first in the area of Parkinson’s disease. The firm has also been collaborating with the Parkinson’s Institute to use a large gene panel to screen patients for genetic variants associated with the disease.

Read more

FierceBiotech Names Compass Therapeutics a 2018 “Fierce 15” Biotech Company

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Compass Therapeutics, a biotechnology company committed to the ambitious goal of comprehensively drugging the human immune system, today announced that it has been named by FierceBiotech as one of 2018’s Fierce 15 biotechnology companies, designating it as one of the most promising private biotech companies in the industry.

Compass, which completed its $132 million Series A financing this year, is forging a new approach to identifying antibody drug candidates that engage all targets in the biologically complex human immune synapse. The company’s antibody discovery platform enables the rapid identification of therapeutic candidates that engage with a broad range of epitopes and its StitchMabs™ bispecific screening platform enables the empirical, high-throughput identification of novel synergistic combinations and bispecifics. To date, the company’s integrated R&D approach has generated therapeutic candidates for more than 30 targets in cancer, inflammation and autoimmune disease. More than 15 of them are now advancing through preclinical development.

Read more